Study aims to Fine-Tune drug dose to reduce blood loss in joint surgery
NCT ID NCT05075200
Summary
This study aimed to find the best dose of a drug called tranexamic acid (TXA) for patients getting hip or knee replacements. TXA helps control bleeding during surgery, which can reduce the need for blood transfusions. Researchers tested how the drug was processed in the bodies of 21 patients, paying special attention to those with reduced kidney function, to help create better dosing guidelines.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHROPLASTY, REPLACEMENT, KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.